ADALUZIS
Dead / Abandoned — Abandoned — no statement of use filed (as of 09 Feb 2026)
What this means for you
This application is over — abandoned 09 Feb 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90849710
- Mark type
- Stylized text
- Filed
- 27 Jul 2021
- Published for opposition
- 08 Nov 2022
- Abandoned
- 09 Feb 2026
- Attorney of record
- Evan A. Raynes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of infectious diseases, for the treatment of dermatological disorders, for the treatment of gastrointestinal diseases, for the treatment of neurological diseases, for the treatment of cardiovascular diseases, and for the treatment of gynecological diseases
Owner
- Basilea Pharmaceutica AG, Basel, CH
- Basilea Pharmaceutica AG, Basel, CH
Prosecution history
- 09 Feb 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Feb 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 09 Feb 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Feb 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 11 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Dec 2025 — SOU EXTENSION 5 GRANTED
- 24 Jun 2025 — SOU EXTENSION 5 FILED
- 10 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 16 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Dec 2024 — SOU EXTENSION 4 GRANTED
- 16 Dec 2024 — SOU EXTENSION 4 FILED
- 16 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 02 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jul 2024 — SOU EXTENSION 3 GRANTED